Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

79.22 -1.85 (-2.28%)
Delayed Quote Updated: 11:18 AM EST, Nov 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Reports Third Quarter 2026 Financial Results
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November
From DexCom, Inc.
Via Business Wire
News headline image
Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Promotes Jereme Sylvain to Chief Operating Officer
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Appoints Glenn Boehnlein to Board of Directors
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Reports Second Quarter 2026 Financial Results
From DexCom, Inc.
Via Business Wire
News headline image
Kaskela Law Firm Announces Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Shareholders with Investment Losses to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
From DexCom, Inc.
Via Business Wire
News headline image
Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:NVO),(NASDAQ:SNY),(NASDAQ:DXCM),(NASDAQ:TNDM) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Further Advances Vision of Glucose Biosensing for All
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
From Dexcom
Via Business Wire
News headline image
Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
From Dexcom
Via Business Wire
News headline image
Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
From DexCom, Inc.
Via Business Wire
News headline image
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom to Host Investor Day on May 14, 2026
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Reports First Quarter 2026 Financial Results
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Appoints Rick Osterloh to Board of Directors
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
News headline image
Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results
From DexCom, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.